about
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Read More
8.00
0.19
(2.43%)
511.5K
XNAS Volume
XNAS 20 Feb, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Immix Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..